Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalnex Solutio. Regulatory News (CLX)

Share Price Information for Calnex Solutio. (CLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.50
Bid: 52.00
Ask: 53.00
Change: 0.50 (0.95%)
Spread: 1.00 (1.923%)
Open: 53.00
High: 53.00
Low: 52.50
Prev. Close: 52.50
CLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of EGM-Replacement

2 Jul 2007 17:36

Calyx Group PLC02 July 2007 Correction - In the Result of EGM announcement released today (RNS 4875Z), thedate of the three meetings was incorrect. The date of the three meetings wasMonday 2 July 2007 and has been correctly disclosed in the announcement below.No other changes have been made to this announcement. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO ORFROM ANY RESTRICTED JURISDICTION Calyx Group plc ("Calyx" or the "Company") Result of Court Meetings and EGM The First Court Meeting was held on Monday, 2 July 2007 to enable CalyxShareholders (other than the Stornoway Class Shareholders) to consider and, ifthought fit, approve the Scheme. The resolution was decided on a poll and theresolution proposed was passed. The number of votes for and against theresolution were as follows: Shares Shareholders (either in person or by proxy) Number % Number %For 31,453,240 99.99% 48 98%Against 1,000 N/A 1 2% The Second Court Meeting was held on Monday, 2 July 2007 to enable StornowayClass Shareholders to consider and, if thought fit, approve the Scheme. Theresolution was decided on a poll and the resolution proposed was passed. Thenumber of votes for and against the resolution were as follows: Shares Shareholders (either in person or by proxy) Number % Number %For 21,419,738 100% 3 100%Against - - - - An Extraordinary General Meeting was held on Monday, 2 July 07 and allresolutions proposed to Calyx shareholders were duly passed. The number ofvotes for and against the resolutions were as follows: Shares Shareholders (either in person or by proxy) Number % Number %Resolution 1 - Ordinary ResolutionFor 50,471,661 99.99% 48 98%Against 1,000 N/A 1 2% Resolution 2 - Special ResolutionFor 50,471,661 99.99% 48 98%Against 1,000 N/A 1 2% Resolution 3 - Special ResolutionFor 50,471,661 99.99% 48 98%Against 1,000 N/A 1 2% Resolution 4 - Ordinary ResolutionFor 50,471,661 99.99% 48 98%Against 1,000 N/A 1 2% Resolution 5 - Simple Majority of votes cast by Independent Shareholders on a pollFor 30,333,923 99.9% 49 98%Against 1,000 N/A 1 2% The anticipated timeline of the remaining principal events required to implementthe Scheme is as follows: Intended Cancellation Record Time: 6.00 pm on 17 July 2007Intended date for Court Hearing (of the petition to sanction the 18 July 2007Scheme):Intended Transfer Record Time: 6.00 pm on 22 July 2007Last day of trading of Calyx Shares on AIM and IEX: 20 July 2007Intended Effective Date of the Scheme: 23 July 2007Dispatch of cheques/electronic settlements (as appropriate): No later than 6 August 2007 Capitalised terms in this announcement have the same meaning as in the SchemeDocument dated 8 June 2007. Enquiries: Calyx Group plc: +353 (0) 1 883 5555Gary Kennedy Davy Corporate Finance: +353 (0) 1 679 6363Financial Adviser to Calyx Group plcRonan GodfreyJohn Frain Murray Consultants: +353 (0) 1 498 0300Public Relations adviser to Calyx Group plcEd Micheau Deloitte Corporate Finance: +44 (0) 20 7936 3000Financial Adviser to Stornoway LimitedJonathan HintonDavid Smith Buchanan Communications: +44 (0) 20 7466 5000Public Relations adviser to Stornoway LimitedTim ThompsonJames Strong The Directors of Calyx accept responsibility for the information contained inthis announcement. To the best of their knowledge and belief (having taken allreasonable care to ensure that such is the case), the information contained inthis announcement for which they take responsibility is in accordance with thefacts and does not omit anything likely to affect the import of suchinformation. This announcement is not intended to and does not constitute an offer to sell orsubscribe for or an invitation to purchase or subscribe for any securities orthe solicitation of any vote or approval in any jurisdiction pursuant to theAcquisition or otherwise. Any response in relation to the Acquisition should bemade only on the basis of the information in the Scheme Document or any documentby which the Acquisition and Scheme are made. Davy Corporate Finance, which is authorised in Ireland by the FinancialRegulator under the Investment Intermediaries Act 1995, is acting exclusivelyfor Calyx and no-one else in connection with the Acquisition and will not beresponsible to anyone other than Calyx for providing the protections afforded toclients of Davy Corporate Finance or for providing advice in relation to theAcquisition. Deloitte Corporate Finance is acting exclusively for Stornoway and no-one elsein connection with the Acquisition and will not regard any other person as itsclient nor be responsible to anyone other than Stornoway for providing theprotections afforded to clients of Deloitte Corporate Finance nor for providingadvice in relation to the Acquisition, or any matter referred to in thisannouncement. Deloitte Corporate Finance is a division of Deloitte & Touche LLP,which is authorised and regulated by the Financial Services Authority in respectof regulated activities. The distribution of this announcement in or into certain jurisdictions may berestricted by the laws of those jurisdictions. Accordingly, copies of thisannouncement and all other documents relating to the Acquisition are not being,and must not be, mailed or otherwise forwarded, distributed or sent in, into orfrom any Restricted Jurisdiction. Persons receiving such documents (including,without limitation, nominees, trustees and custodians) should observe theserestrictions. Failure to do so may constitute a violation of the securities lawsof any such jurisdiction. Any person who is a holder of one per cent. or more of the Calyx Shares may havedisclosure obligations under Rule 8.3 of the Takeover Rules, effective from thedate of the commencement of the offer period in respect of the Acquisition. 2 July, 2007 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th May 20227:00 amRNSNotice of Investor Presentation
26th Apr 20229:13 amRNSAward of Options
22nd Apr 202210:50 amRNSHolding(s) in Company
21st Apr 20223:37 pmRNSPDMR Dealing
21st Apr 20227:00 amRNSCalnex receives two Queen’s awards for Enterprise
12th Apr 20227:00 amRNSAcquisition of iTrinegy and Update on Trading
1st Mar 20227:00 amRNSTrading Update
25th Jan 202210:00 amRNSDirector Dealing
11th Jan 20227:00 amRNSBoard Appointments
29th Nov 20212:00 pmRNSPrice Monitoring Extension
26th Nov 20219:55 amRNSHolding(s) in Company
23rd Nov 20214:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20214:35 pmRNSPrice Monitoring Extension
23rd Nov 20212:06 pmRNSSecond Price Monitoring Extn
23rd Nov 20212:00 pmRNSPrice Monitoring Extension
23rd Nov 20217:00 amRNSInterim Results
10th Nov 20217:00 amRNSNotice of Results and Investor Presentation
3rd Nov 202111:03 amRNSHolding(s) in Company
15th Oct 20219:33 amRNSPDMR Dealing
12th Oct 20217:00 amRNSTrading Update
7th Sep 20217:00 amRNSAward of Options
19th Aug 20215:05 pmRNSResult of AGM
19th Aug 20217:00 amRNSAGM Statement
4th Aug 20214:34 pmRNSHolding(s) in Company
15th Jul 20212:53 pmRNSDirector Dealing
28th Jun 20217:00 amRNSNotice of AGM and Posting of Annual Report
16th Jun 20214:26 pmRNSPDMR Dealing
25th May 20217:00 amRNSFY21 Final Results
17th May 20217:00 amRNSNotice of Results and Investor Presentation
15th Apr 202112:31 pmRNSPDMR Shareholding
1st Apr 20214:05 pmRNSPDMR/PCA Dealing
24th Mar 20214:14 pmRNSPDMR Dealing
16th Feb 20217:00 amRNSTrading Update
1st Feb 20213:53 pmRNSPDMR Dealing
10th Dec 20202:05 pmRNSSecond Price Monitoring Extn
10th Dec 20202:00 pmRNSPrice Monitoring Extension
25th Nov 202011:05 amRNSSecond Price Monitoring Extn
25th Nov 202011:00 amRNSPrice Monitoring Extension
25th Nov 20209:00 amRNSPrice Monitoring Extension
25th Nov 20207:00 amRNSInterim Results
23rd Nov 20202:01 pmRNSPrice Monitoring Extension
23rd Nov 202011:05 amRNSSecond Price Monitoring Extn
23rd Nov 202011:00 amRNSPrice Monitoring Extension
23rd Nov 20209:05 amRNSSecond Price Monitoring Extn
23rd Nov 20209:00 amRNSPrice Monitoring Extension
12th Oct 20206:10 pmRNSHolding(s) in Company
8th Oct 20207:00 amRNSHolding(s) in Company
6th Oct 20207:00 amRNSHolding(s) in Company
6th Oct 20207:00 amRNSHolding(s) in Company
5th Oct 20207:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.